S. Grant

发表

Extended-Release Niacin Therapy and Risk of Ischemic Stroke in Patients With Cardiovascular Disease: The Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides Impact on Global Health Outcome (AIM–HIGH) Trial

David C. Anderson, B. Chaitman, L. Goldstein, 2013, Stroke.

Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry

J. Kremer, V. Strand, K. Saunders, 2017, Rheumatology and Therapy.

Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial

J. Kublin, D. Montefiori, N. Frahm, 2018, The lancet. HIV.

Injectable Tumor Necrosis Factor α Inhibitors and Outpatient Antimicrobial Use in Children With Rheumatic Diseases: Analyses of Prescription Claims From a Pharmacy Benefit Manager Database

S. Sullivan, C. Wallace, S. Ringold, 2013, Arthritis care & research.

SAT0263 Biologic Therapy, Time to Low Disease Activity, and Effect of Mono Vs. Background Oral Dmard Therapy Among Psoriatic Arthritis Patients in a US Registry.

J. Greenberg, D. Collier, K. Saunders, 2013 .

Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.

S. Hammer, H. Liao, T. Hertz, 2016, The Journal of infectious diseases.

Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial

Lindsay N. Carpp, Vicki C. Ashley, Allan C. deCamp, 2022 .

Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study

J. Kublin, D. Montefiori, O. Hyrien, 2021, PLoS medicine.

Transient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV Infection

S. Buchbinder, M. McElrath, S. D. De Rosa, 2016, PloS one.

Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial

J. Kublin, D. Montefiori, N. Frahm, 2019, The lancet. HIV.

Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans

G. Pantaleo, M. McElrath, P. Gilbert, 2021, NPJ vaccines.

Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials

J. Fuchs, N. Frahm, G. Pantaleo, 2021, PLoS pathogens.

Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants

J. Andriesen, Yunda Huang, G. Tomaras, 2023, PLOS global public health.

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines

J. Kublin, D. Montefiori, N. Frahm, 2020, PLoS medicine.

Selection of HIV vaccine candidates for concurrent testing in an efficacy trial.

Allan C. deCamp, J. Kublin, S. Buchbinder, 2016, Current opinion in virology.

OP0064 Discontinuation of Biologic Therapy in Rheumatoid Arthritis (RA): Analysis from the Consortium of Rheumatology Researchers of North America (CORRONA) Database

V. Strand, P. Miller, K. Saunders, 2013 .

HIV Sexual Risk and Syndemics among Women in Three Urban Areas in the United States: Analysis from HVTN 906

V. Frye, D. Dunbar, I. Frank, 2015, Journal of Urban Health.

Methotrexate and Injectable Tumor Necrosis Factor-α Inhibitor Adherence and Persistence in Children with Rheumatic Diseases

S. Sullivan, C. Wallace, S. Ringold, 2013, The Journal of Rheumatology.

Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial

Lindsay N. Carpp, Vicki C. Ashley, Allan C. deCamp, 2018, The Journal of infectious diseases.

Extended-Release Niacin Therapy and Risk of Ischemic Stroke in Patients With Cardiovascular Disease: The Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides Impact on Global Health Outcome (AIM–HIGH) Trial

David C. Anderson, B. Chaitman, L. Goldstein, 2013, Stroke.